Terms ending in 2027
Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,183,230 | Antimicrobial Preservatives to Achieve Multi-Dose Formulation Using Beta-Cyclodextrins for Liquid Dosage Forms In force · High confidence | Zoetis Services LLC | In force | High confidence | |
| US RE45,847 | Antibodies to Madcam In force · Low confidence | Amgen Fremont Inc. | In force | Low confidence | |
| US 8,080,646 | Human Monoclonal Antibodies to Activin Receptor-Like KINASE-1 In force · High confidence | Amgen Fremont Inc. | In force | High confidence | |
| US 7,811,263 | Dose Metering Mechanism for an Injection Device In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 8,987,320 | Solid Salt Forms of a Pyrrole Substituted 2-Indolinone In force · Medium confidence | Zoetis Services LLC | In force | Medium confidence | |
| US 7,888,508 | Pyrrolo[2,3-b]pyridine Derivatives Active as Kinase Inhibitors In force · High confidence | Nerviano Medical Sciences S.R.L | In force | High confidence | |
| US 9,211,659 | Capsule Formation In force · High confidence | Capsugel Belgium N.V. | In force | High confidence | |
| US 9,655,860 | Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture In force · Medium confidence | Capsugel Belgium N.V. | In force | Medium confidence | |
| US 10,004,692 | Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture In force · Low confidence | Capsugel Belgium N.V. | In force | Low confidence | |
| US 7,728,140 | Pyrrolo[2,3-b]pyridine Derivatives Active as Kinase Inhibitors and Pharmaceutical Compositions Comprising Them In force · Medium confidence | Nerviano Medical Sciences S.R.L | In force | Medium confidence | |
| 3 more term ends in 2027 · Pro | |||||
10 of 13 patents shown. Soonest term end first, then patent number.
Pro members see all 13, all of them expiring within the 18 months from Nov 17, 2026.
5 of these are in force and held by Pfizer Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.